Special Use Investigation of HALAVEN (HAL03T) - Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas
Special Use Investigation of HALAVEN (HAL03T) - Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas
The purpose of this study is to understand safety and efficacy in participants with soft tissue sarcomas.
Inclusion Criteria:
- Participants with soft tissue sarcoma who will receive eribulin mesylate per the approved indication in routine clinical practice
Exclusion Criteria:
- None